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Genomic imprinting in mammals results in the expression of genes from only one parental allele. Imprinting occurs as a
consequence of epigenetic marks set down either in the father’s or the mother’s germ line and aﬀects a very specific category
of mammalian gene. A greater understanding of this distinctive phenomenon can be gained from studies using large genomic
clones, called bacterial artificial chromosomes (BACs). Here, we review the important applications of BACs to imprinting research,
covering physical mapping studies and the use of BACs as transgenes in mice to study gene expression patterns, to identify
imprinting centres, and to isolate the consequences of altered gene dosage. We also highlight the significant and unique advantages
that rapid BAC engineering brings to genomic imprinting research.
1. Introduction
Genomic imprinting describes a unique class of genes that
are expressed from only one parental allele as a consequence
of epigenetic marks set down either in the father’s or the
mother’s germ line [12] (Figure 1). Essentially, although
two gene copies are physically present within each diploid
somatic cell, only one gene copy is transcriptionally active,
producing an RNA product. The first evidence that individ-
ual genes were imprinted came from studies on the mouse
Insulin-like growth factor 2 (Igf2) gene [13]. An embryonic
growth restriction phenotype was apparent in heterozygous
oﬀspring after paternal transmission of a targeted deletion
of this locus initially suggesting haploinsuﬃciently. However,
heterozygous animals also had unexpectedly low levels of
expression of Igf2 rather than the anticipated 50% reduction.
Imprinting of the locus was subsequently demonstrated
genetically [14]. In quick succession, a receptor for Igf2, Igf2r,
and one of themost abundant RNAs in the developingmouse
embryo, H19, were found to be maternally expressed [15,
16]. Thus, in short succession, allele-specific gene expression
was demonstrated for three genes in mice. We now know of
at least 80 protein-coding genes that are imprinted in both
mouse and human. Many of these genes play important roles
in early development, and many are physically linked within
domains of both maternally- and paternally-expressed genes.
This work is summarized at http://www.mousebook.org/.
Imprinted genes within domains are regulated by discrete
genomic regions called imprinting centres (ICs) [17]. These
regions, which can also be referred to as imprint control
elements (ICEs) or imprint control regions (ICRs), are
functionally defined by engineering-targeted deletions in
mice [18–32]. Inheritance of an IC deletion through one
parental germ line releases all the genes within the domain
from their imprinted expression (loss of imprinting, LOI)
whereas inheritance through the other parent’s germ line
generally, but not always, has no consequence. These ICs
carry a DNA methylation imprint on one parental allele
only, and studies on the DNA methyl-transferases (Dnmts)
Dnmt3a and Dnmt3b and the accessory protein Dnmt3L
demonstrate the necessity of de novo DNA methylation for
the establishment of allele-specific gene expression [33–37].
Much of our understanding of the mechanism and
function of genomic imprinting is based on data from the
targeted deletion of imprinted genes, trans-factors or ICs
in mice. However, while studies on loss of function are
important for our understanding of gene function per se,
imprinting is a dosage-related phenomenon. Altering the
dosage of the imprinted gene is more informative with
respect to the function of the imprint. Furthermore, while
targeted deletions of ICs may confirm the requirement of a
region for imprinting, further painstaking work is required
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Table 1: Summary of BAC transgene models used to test for autonomous imprinting.
Gene (s) Size
Imprinting (Lines
imprinting/lines
tested)
Expression in embryo Reference
Nnat 270 kb BAC 1/1 Full [1]
Nnat 95 kb BAC 2/3
Partial (lacking neural
enhancers)
[1]
Cdkn1c 260 kb BAC 0/2 Full (Cdkn1c) [2]
Cdkn1c 85 kb BAC 0/4 Partial [2]
Peg3/Zim1 120 kb BAC 1/3(Peg3 only)
Neural expression of
Peg3 but fails to
rescue Peg3-deficiency
[3]
Gtl2 178 kb BAC 2/2 Partial [4]
ZAC1/HYMAI 175 kb PAC 2/2
Full expression by in
situ
[5]
Necdin and Magel 109 kb∗ BAC 0/1 Partial (Necdin) [6]
Igf2r 170 kb BAC 4/4 Full [7]
Dlk1/Gtl2 70 kb BAC 0/3 Full (Dlk1) [8]
Table 2: Functional consequence in transgenic overexpression models.
Gene dosage
Expressed
allele
Embryonic phenotype EE phenotype Reference
2 X Cdkn1c
(1 copy BAC)
Maternal
E13.5 embryos 80% WT
Proportional decrease in the
weight of internal organs such as
kidney, lung, and liver
No placental expression [9]
3 X Phlda2 and Slc22a18
(2 copy BAC)
Maternal
E13.5 embryos similar to WT
E16.5 embryos 90% WT weight
E18.5 embryos 87% WT
E14.5 placentae 80% WT [10, 11]
2 X Dlk1/Gtl2
(4–7 copies BAC)
Paternal E16.5 embryos 110% WT No placental expression [8]
Diploid
primordial
germ cell
Oocyte
Female
gametogenesis
Sperm
Haploid gametes
Male
gametogenesis
Igf2
Igf2 H19
H19
Igf2 H19
DNA methylation
Diploid somatic cell
Fertilisation
Monoallelic
expressed from
only one parental
chromosome
Biallelic
expressed from
both chromosomes
Figure 1: During mammalian gametogenesis, the diploid primordial germ cell undergoes meiosis to produce haploid male and female
gametes. As meiosis progresses, specific DNA sequences acquire a DNA methylation imprint (black lollypops) in one parental germline but
not the other. After fertilization, this imprint is recognized within the somatic cells establishing an imprinted domain. Maternal inheritance
is indicated in red and paternal inheritance is indicated in blue.
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Figure 2:Mouse distal chromosome 7 contains two complex imprinted loci. (a) A diagrammatic representation ofmouse distal chromosome
7 with maternal inheritance indicated in red and paternal inheritance indicated in blue. Genes are represented by the black boxes with the
parent-of-origin expression indicated by either a red (maternal) or blue (paternal) arrow. Biallelic expression is indicated by a black arrow.
Noncoding RNAs are represented by dashed arrows. DNA methylation is represented by the black lollypops. Green boxes indicate position
of ICs whilst green doubleheaded arrows indicate the region influenced by the IC. (b) BAC clones that are used to examine expression,
imprinting, and function. Blue boxes indicate the position of lacZ insertion. (c) Images of transgenic embryos inheriting the modified BACs
through either thematernal or paternal germline as indicated by gender symbols below image. Expression ofCdkn1c from the BAC is revealed
by lacZ reporter expression.
to dissect the function of these regions and to identify each
element of the imprinting process. Transgenes provide an
essential tool to our armory. A transgene-based approach can
provide information both on the mechanism of imprinting
and also the functional consequences of increased gene
expression in a single model. In this respect, transgenes based
on bacterial artificial chromosomes (BACs) have been of
particular value.
2. BACs
BACs were first developed as a large insert clone system to
facilitate the construction of an orderly set of overlapping
clones as tools for the Human Genome Project [38]. BACs
are single copy replicons based on the naturally occurring
Escherichia coli fertility plasmid. This vector system is capable
of cloning and propagating large DNA fragments with an
average insert size of 150 kb and a maximum insert size
of 700 kb. The key advantage of BACs over other large
insert technologies is their stability in culture and ease
of manipulation. These qualities initially rendered them
an ideal resource for physically mapping genomes and
they have been used in almost all the genome sequencing
projects [38]. One major advantage that large insert clones
bring to transgenic research is that they are more likely
to contain the necessary promoter, enhancer, and silencer
combination to mimic the natural expression of the gene
of interest. The advantages of the BAC transgenic approach
compared to a conventional transgenic approach have been
discussed extensively elsewhere [39]. However, there are
several advantages that BACs bring that are specific to
imprinting research. Firstly, the imprinting capacity of BACs
carrying both target genes and putative ICs can be examined
outside the normal chromosomal context. Secondly, BACs
can be used to study the developmental consequence of
accurate but excess expression of single genes. And thirdly,
their amenability to modification techniques to insert or
delete sequences and to alter sequences as discrete as a
single point mutation [40–44] makes them a powerful tool
for addressing both mechanistic and functional questions.
BACs can be modified rapidly in vitro, with an average
construction time of less than 4 weeks. Once the modified
BAC is made, transgenic founders can be generated by the
pronuclear injection of the construct into fertilised eggs
to generate transgenic founders. Thus, modified BACs can
provide an important additional tool, alongside traditional
targeting of endogenous loci in embryonic stem (ES)
cells.
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Figure 3: Mouse distal chromosome 2 contains a minimalistic imprinted locus. (a) A diagrammatic representation of mouse distal
chromosome 2 imprinted region withmaternal inheritance indicated in red and paternal inheritance indicated in blue. Genes are represented
by the boxes with the parent-of-origin expression indicated by either a red (maternal) or blue (paternal) arrow. DNA methylation is
represented by the black lollypops. Green box indicates position of proposed IC whilst green doubleheaded arrow indicates the known
region influenced by this IC. (b) BAC clones and subclone used to examine expression, imprinting, and function. Blue boxes indicate the
position of lacZ reporter. (c) Images of transgenic embryos inheriting the modified BACs through either the maternal or paternal germline
as indicated by gender symbols below image. Expression of Neuronatin from the transgenic insertion is revealed by lacZ reporter expression.
3. Physical Maps of Imprinted Domains
BACs were first applied to imprinting research in order
to generate physical maps of imprinted domains. Early
work suggested that imprinted genes were not randomly
scattered throughout the chromosomes but localized to dis-
crete domains containing both maternally- and paternally-
expressed genes. This featuristic organization is ideally
suited to the construction of contigs of large genomic
clones. Firstly, to provide detailed information about the
physical organization of the known genes within the domain.
Secondly, to extend the contigs to identify physically linked
genes and test their imprint status. Thirdly, and perhapsmost
importantly, to identify nongenic regions of conservation
between diﬀerent species as likely ICs.
The first imprinted region to be physically mapped using
BACs was human chromosome 11p15.5 [45]. This region has
been the focus of intense study because of the association
with the classic imprinting disorder, Beckwith Wiedemann
Syndrome (OMIM 130650; BWS). First human and then
mouse contigs [2, 46–48] provided templates for sequencing
to reveal information on the location of genes, their physical
structure, and also the location of genomic sequence features
conserved between mouse and human. This approach was
important in identifying both a conserved putative IC (IC2)
carrying a germ line imprint and also novel genes located
inside and outside the previously proposed boundaries of
the imprinting cluster [49, 50]. BACs have subsequently
been similarly employed to physically characterize additional
imprinted loci including SNRPN, MEST/PEG1, Peg3/Zim1,
Dlk2/Gtl2, Gnas, and Neuronatin [1, 3, 51–56].
4. BACs and Studies on
the Evolution of Imprinting
The construction of BAC libraries for a variety of species
provides unprecedented resources for advancing the ongoing
research into genomic imprinting. These resources have
particular relevance to studies on imprinting because, while
imprinting has been demonstrated in marsupial and euthe-
rian mammals, it has not been reported in monotremes
(platypus and echidna) or nonmammalian vertebrates. This
suggests that imprinting arose sometime after the divergence
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of monotremes (prototherians) from therian mammals,
which has important implications for understanding the
rational for this phenomenon [57]. Comparing genomic
regions in key representatives of mammalian diversity and
phylogeny will be of great value in unlocking further secrets
of genomic imprinting.
As the most intensively investigated imprinted domain in
the human and mouse genomes, the BWS imprinted region
has also been scrutinized in nonmammalian vertebrates
through the isolation of BAC clones [58, 59]. This work was
important in establishing that the imprinted genes within
this domain were physically linked prior to acquisition of
their imprint. Orthologues of a number of imprinted genes
have also been isolated from BAC libraries constructed
from the genomes of the tammar wallaby (marsupial)
and the platypus (monotreme) [60]. Mapping these BACs
to their respective chromosomes demonstrated that these
imprinted gene orthologues existed on separate chromo-
somes prior to the evolution of imprinting. This finding
suggests that genomic imprinting evolved independently
from X-inactivation, despite similarities in the epigenetic
mechanisms directing these two processes.
In eutherian mammals, imprinted domains are regulated
by imprinting centres [17]. Using these DNA sequences
directly as probes to identify orthologous regions in other
species has not been successful. This is most likely due to
their high GC content (sticky probes) and the relatively
low conservation of DNA sequence, even between human
and mouse. However, BACs can be identified that span
regions predicted to contain ICs by using sequences from
nearby protein-coding genes as baits. As an example, an
SGCE/PEG10 tammar wallaby BAC was isolated using a
mouse Sgce cDNA as a probe [61]. The BAC also contained
a diﬀerentially methylated region (DMR) equivalent to that
observed in eutherians providing the first evidence that
DNA methylation is a conserved feature of the imprinting
mechanism. This work highlighted another added value of
BACs in cross-species studies. The tammar wallaby PEG10
gene was not identified in a direct screen but by primer
walking from the physically-linked SGCE. Employing the
same methodology, researchers were unable to identify any
sequence with similarity to PEG10 within the platypus
SGCE BAC contig, thus, demonstrating that the PEG10 was
inserted into the genome after monotremes diverged from
the other lineages. Thus, not only has the mechanism for
imprinting genes arisen at a critical time in the evolution of
modern mammals, but also new genes have been added to
the genome with entirely novel functions.
5. BACs as Transgenes
In addition to physical mapping studies, BACs have provided
useful tools for establishing the expression and imprinting
capabilities of specific genomic regions within imprinted loci
(Table 1). Putative ICs for imprinted domains can initially
be identified by their epigenetic characteristics (diﬀerential
DNA methylation). These regions can subsequently be
functionally defined by targeted deletion of the endogenous
locus (see earlier). Another stringent test for imprint control
regions is to examine their function at ectopic loci. If a
sequence can direct imprinting when integrated randomly
into the genome, this suggests that all the component parts
of the imprinting mechanism are contained within this
sequence.
The first transgenic studies of this sort relied on plasmid-
based transgenes. However, the smaller transgenes were
of limited use primarily because the site of integration
can influence both expression and imprinting [62] but
also because small transgenes were less likely to carry all
the required elements to recapitulate expression of the
endogenous locus. These disadvantages were overcome by
increasing the size of the genomic region included in the
transgene. The Igf2/H19 locus on mouse distal chromosome
7 and the Igf2r locus on mouse chromosome 17 were the
first imprinted regions to be transgenically dissected using
large genomic clones [63, 64]. YACs were used in both cases.
Imprinted expression was reliably established away from the
respective domains indicating that the cis-sequences required
to establish imprinting lay within the genomic regions
encompassed by these YACs. BACs have largely rendered
YACs obsolete for these types of study because of their
relative stability in culture and ease of DNA preparation
[65] and, most importantly, the development of technologies
to insert or remove specific sequences, reviewed recently
[39, 66]. Sequences, such as reporters, can be homologously
recombined into BACs to provide useful information on
both spatial and imprinted expression. Where BACs contain
more than one gene or where overexpression might be non-
viable, homologous recombination can be used to inactivate
gene loci [1, 2, 9, 10]. As a future goal, putative ICs could be
mutated at the single nucleotide level to explore mechanistic
questions or conditionally targeted in order to examine the
temporal requirement for these sequences. Although these
latter procedures can be performed at the endogenous IC,
the major advantage that BAC modification protocols have
over targeted homologous recombination in ES cells is speed.
Once a targeting vector is constructed, BACs can be modified
in a matter of weeks and then injected into fertilized mouse
oocytes to generate founders within a few months.
Cdkn1c (previously known as p57Kip2) and Neuronatin
(previously known as Peg5) were the first imprinted loci to
be mechanistically explored using BACs [1, 2]. Cdkn1c maps
to the BWS imprinted region on mouse distal chromosome
7/Human chromosome 11p15. This is one of the most
complex imprinted regions in mice containing at least
18 maternally- and paternally-expressed genes and three
DMRs (Figure 2(a)). In mice, the region can be separated
mechanistically into two distinct domains, termed the IC1
and IC2 domains [20–22, 26, 67]. Cdkn1c maps within
the IC2 region. The fact that the regulatory elements were
located at a distance from Cdkn1c was first suggested by
studies on a 38 kb cosmid-based transgene spanning the
human CDKN1C locus [68]. Despite containing 20 kb of
sequence upstream and 15 kb of sequence downstream of
the gene, CDKN1C was not expressed from the human
transgene in multiple lines. Transgenic expression of Cdkn1c
was only achieved using larger murine BAC-based trans-
genes suggesting the existence of distantly-located enhancers
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[2]. Two BACs spanning the murine Cdkn1c gene, of 85
and 260 kb, respectively, were engineered to include a β-
galactosidase reporter under the control of the Cdkn1c pro-
moter (Figure 2(b)). Whole-mount LacZ analyses provided
easy access to the expression pattern of the Cdkn1c gene
under control of regulatory elements within the BAC. From
the smaller BAC, Cdkn1c-lacZ was expressed in a subset of
tissues in which the endogenous Cdkn1c locus was expressed
whereas the much larger 260 kb BAC drove expression in
all embryonic tissues (Figure 2(c)). Enhancers for extraem-
bryonic tissues lay outside the 320 kb region scanned. The
murine Cdkn1c gene is spanned by a DMR [68], but neither
BAC transgene autonomously imprinted Cdkn1c [2]. A
second DMR within the IC2 region, called KvDMR1, has
now been functionally defined as the imprinting centre for
the region controlling imprinted expression of Cdkn1c and
the other maternally-expressed genes [26]. This imprinting
centre is contained within the 260 kb Cdkn1c BAC so, in
theory, it should imprint at ectopic chromosomal loci. This
was not the case suggesting that KvDMR1 requires additional
elements to function as an IC. Currently, only an 800 kb YAC,
which encompasses almost the entire IC2 domain, has the
capacity to imprint Cdkn1c [67].
Adjacent to the IC2 domain lies the IC1 domain,
which spans Igf2, Ins2, and H19 (Figure 2(a)). Igf2/H19
were initially shown to imprint at ectopic loci from a
130 kb YAC [63], and a 137 kb BAC was used to further
refine the minimal region required to imprint H19 to
−7 kb and +35 kb of the H19 promoter [69]. This region
contains the functionally defined IC just upstream of H19
[20–22]. Although smaller transgenes can drive imprinted
expression of H19, they do so unreliably and without
inducing germline DNAmethylation at the ICwhereas the IC
within the larger BAC clone does become DNA methylated
in the male germline [70]. These data suggest that, while
ICs initiate the imprinting mechanism, the surrounding
sequence is important in interpreting and maintaining the
process.
The paternally expressed Neuronatin gene maps to one
of the least complex imprinted domains, located on mouse
distal chromosome 2/Human chromosome 20 (Figure 3(a)).
Neuronatin is not located within a cluster of imprinted
genes but lies within the intron of a second gene, Blcap
(previously known as Bc10) [1]. Blcap shows a maternal-
allele bias in expression in tissues where Neuronatin is highly
expressed, transcriptional interference rather than a direct
imprint [71]. The body of the Neuronatin gene carries direct
diﬀerential DNA methylation on the maternal allele and
within this DMR, there is a smaller region that exhibits the
biochemical characteristics of an IC [1, 72]. Transgenic mice
engineered with a series of BAC clones modified to include a
β-galactosidase reporter under the control of the Neuronatin
promoter were used to demonstrate that the minimum
sequence required to imprint Neuronatin was approximately
30 kb and, indeed, encompassed the putative IC (Figures 3(b)
and 3(c)). In addition, these studies revealed that enhancers
for tissue-specific expression of Neuronatin were primarily
located upstream of the putative IC and that some of them
lay at a significant distance from the body of the gene.
Overlapping BAC transgenes have also been used
to explore the Delta-like1 (Dlk1)/Gene-trap locus2 (Gtl2)
imprinted domain on mouse chromosome 12. Imprinted
expression of Gtl2 was reported from a 178 kb BAC that
spans a region from 3.5 kb upstream of the physically linked
Delta-like1 (Dlk1) gene to 69 kb downstream of Gtl2 [4].
This Dlk1/Gtl2 BAC drove expression of Gtl2 in a subset
of tissues in which the endogenous locus is expressed, but
Dlk1 was not expressed from this BAC in any tissue. Dlk1
was expressed from a smaller 70 kb BAC encompassing more
sequence upstream of Dlk1 gene, but expression was not
imprinted, thus confirming the location of the IC linked to
Gtl2 [8].
Some BAC studies are more diﬃcult to interpret. The
120 kb BAC spanning the Peg3/Zim1 locus, which contains
20 kb of sequence upstream of Peg3 and 80 kb of sequence
downstream, showed imprinted expression of Peg3 in one
transgenic line but not in two others [3]. Peg3 is spanned
by a germline DMR [73, 74] which suggests that the IC
for Peg3 is contained within this 120 kb BAC. Like the ICs
for H19/Igf2 and Cdkn1c, perhaps the Peg3 IC is reliant on
additional sequences to fully communicate the imprinting
signal.
6. Functional Studies of Imprinted Genes
Providing the appropriate regulatory elements that are also
present, genes are expressed from BACs with spatial and
temporal accuracy and at similar levels to the endogenous
loci, predominantly without being aﬀected by the site of inte-
gration [75]. Consequently, BACs can be used to precisely
engineer increased dosage of gene loci. This has particular
relevance to studies on imprinted loci because gene dosage
is key to the phenomenon. Genomic imprinting alters the
expression level of a particular gene from one parental
allele without altering its essential function. Therefore,
engineering altered dosage of an imprinted gene addresses
the function of the imprint as well as the function of the
gene. Modifying the endogenous locus by targeting an IC
is one route to engineering biallelic expression, recently
reviewed [76]. These models can provide excellent tools for
understanding the consequences of increased gene dosage,
particularly where the IC controls a few well-characterized
targets. However, LOI can mean increased dosage of some
genes (gene activation) and loss of expression of others (gene
silencing). Furthermore, the majority of imprinted domains
are complex and not fully characterized. Interpreting the
results of these studies with respect to individual genes is not
straightforward.
The critical advantage that BAC transgenes provide over
LOI models for exploring the function of imprinting is
that the exact nature and number of genes is precisely
defined by the transgenic sequence assigning phenotypes
unequivocally to the gene sequences within the transgene.
BACs may also be useful in “rescuing” phenotypes associated
with LOI of complex domains, particularly in cases where
loss of expression of one gene within the domain preclude
a phenotypic assessment of other genes. Most importantly,
the ability to rapidly modify BACs is particularly helpful
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in situations where more than one gene is present in close
proximity.
Functional studies performed on the imprinted locus
containing the three closely linked genes, Phlda2, Slc22a18,
and Cdkn1c, provide a textbook example of the advantages
that BACs bring to imprinting research [9–11]. These three
genes are all contained within a 40 kb region of IC2 domain.
Their close proximity means that it would likely be impos-
sible to separate the genes on individual genomic fragments
and still maintain appropriate temporal and spatial expres-
sion. However, when an 85 kb transgene spanning this locus
was found to contain the placental enhancers for Phlda2 and
Slc22a18 but not for Cdkn1c, this allowed the assignment
of a placental stunting phenotype to overexpression of
just Phlda2 and/or Slc22a18 [11]. The placental stunting
phenotype is reciprocal to placentomegaly induced by loss
of expression of Phlda2 [77]. This suggested that Phlda2 acts
as a rheostat for placental growth, with overgrowth after
gene deletion and growth retardation after loss of imprinting
[11]. A key role for Phlda2 in regulating placental weight
and glycogen storage was genetically verified by combining a
single copy of the BAC transgene with a maternally-inherited
targeted deletion of Phlda2 to rescue Phlda2 overexpression
[10]. Essentially, these double transgenic mice have wild-
type levels of Phlda2, but Slc22a18 remains in excess. Their
placentae were phenotypically indistinguishable from wild
type, thus excluding a role for Slc22a18 in placental growth
restriction.
In addition to exhibiting placental growth restriction,
the Cdkn1c/Phlda2/Slc22a18 BAC transgene also restricted
embryonic growth from E13.5. This early growth restriction
phenotype was genetically assigned to excess Cdkn1c and not
excess Phlda2 or Slc22a18 by engineering a modification to
abolish Cdkn1c expression from the BAC. Mice carrying the
modified BAC, with excess Phlda2 and Slc22a18 expression
but normal levels of Cdkn1c, were not growth restricted at
E13.5, thus providing genetic evidence that Cdkn1c encodes
a potent negative regulator of embryonic growth [9]. In
addition to assigning the early embryonic phenotype to
excess Cdkn1c, ablation of Cdkn1c function from the BAC
transgene uncovered a second distinct growth restriction
phenotype. Mice carrying the modified BAC (no Cdkn1c
overexpression) were the same weight as nontransgenic
embryos at E13.5 but showed a progressive loss of growth
potential later in gestation, being 13% lighter that controls by
birth [10, 11]. This suggests a role for Phlda2 and/or Slc22a18
in regulating late embryonic growth. This phenotype would
have been missed by any other approach as the earlier
Cdkn1c-induced growth restriction phenotype eﬀectively
obscures the later phenotype. This study perfectly illustrates
the way in which subtle phenotypes associated with altered
expression of one imprinted gene within a domain can be
masked by other closely linked genes.
Functional BAC-based studies have also been per-
formed on the Dlk1 locus [8] (Table 2). Dlk1, also known
as Preadipocyte factor 1 (Pref-1), encodes an inhibitor
of adipocyte diﬀerentiation. Loss of expression of this
paternally-expressed gene in mice results in growth retar-
dation, obesity, abnormal eyelids, skeletal malformation,
and increased serum lipid metabolites [78]. Examining the
consequence of overexpression of Dlk1 in isolation was
only achievable using a 70 kb BAC transgene containing
49.4 kb of sequence upstream of Dlk1 and 18 kb downstream
of the Dlk1 transcriptional start site. In contrast to the
studies on Cdkn1c and Phlda2, Dlk1 was expressed at
approximately the endogenous level from the BAC transgene
regardless of copy number. However, a triple dose of
Dlk1 was achieved by generating mice homozygous for the
transgene. The 70 kb BAC recapitulated the spatiotemporal
expression of the Dlk1 in embryonic tissues but not in the
placenta. The study revealed an intriguing dual role for
Dlk1 in driving embryonic overgrowth but with significantly
reduced fitness after birth, demonstrating that Dlk1 is a
dosage-critical gene within its domain, a key principle of
imprinting.
7. Future Work
Initial studies on BACs have demonstrated their importance
in both dissecting imprinting mechanisms and understand-
ing imprinting function. Our ability to target BAC transgenes
to specific loci as single copies would improve this technol-
ogy. Such an approach would be useful in rigorously testing
the imprinting capacity of diﬀerent BAC clones within a
single chromosomal location. Single-copy BACs would also
“restore” biallelic expression to specific imprinted loci, a
critical component of functional studies. Current approaches
to generate BAC transgenic mice involve either pronuclear
microinjection into fertilised eggs or electroporation into ES
cells. Both these techniques result in the random integration
of BAC clones into the mouse genome. This can cause
variability due to diﬀerences in the copy number of the BAC
and also position eﬀects caused by the site of integration,
albeit with low frequency compared to plasmid-based clones.
As a result, multiple independent founder lines must be
analysed. In addition, multiple copy number integrations
can result in high levels of gene expression, which are less
relevant to studies on genomic imprinting. Recently, BACs
have been modified to contain the sequences necessary for
homologous recombination into, and complementation of,
the partially deleted hypoxanthine phosphoribosyltransferase
(Hprt) locus in ES cells with positive selection for Hprt to
achieve single-copy integrations [79]. Further developments
could be based on recombining pre-existing loxP sites within
some BAC vectors and one inserted at the Rosa26 locus [80],
bypassing the necessity for any modification of the BAC.
BACs may be useful in addressing further important
questions. For example, we know that ICs are required
to establish imprinted expression within their domains.
However, what happens if these ICs are deleted after the
imprint has been established? Can domains maintain their
imprinted status in the absence of continued signaling from
their ICs? The ability to conditionally target ICs will provide
important information on their role initiation of the imprint
verses maintenance of imprinting. This is not a specific
advantage to BACs since loxP sites can be targeted at the
endogenous locus or to a BAC. However, performing these
studies on a BAC clone would circumvent cases where loss
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of imprinting at the endogenous locus results in embryonic
lethality, allowing studies in the adult.
Our ability to rapidly modify BACs in vitro would also
make two-step sequential modifications more practical. BAC
recombineering could then be used to generate a single clone
containing two diﬀerent regions flanked either by loxP-loxP
sites or by FRT-FRT/loxP sites allowing sequential deletion
of these regions in vivo Cre- and FLPe-recombinases, respec-
tively.
In addition, modified BAC clones are now being used
themselves as targeting vectors. Plasmid-based targeting
vectors cover relatively short regions of the genome of a few
kilobases. BACs can be used to generate targeting vectors
where the two loxP sites are placed far apart. Such an
approach would facilitate the generation of models aimed at
the conditional deletion of larger genomic regions spanning
two or more genes.
In summary, we have provided key examples of how
BAC transgenesis has so far provided a powerful tool to
study genomic imprinting. BACs can be used to address
both mechanistic and functional questions. Our ability
to rapidly modify BACs in vitro suggests that they have
the potential to significantly further our understanding of
genomic imprinting.
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